Search research articles
Contact Us
Filters
Showing results (251-260 of 274) with videos related to
Page
of 28
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
March 30, 2026
Epitaxy Beyond Periodic Lattices: Interfacial Modulation Enabled by Defect State 2D Materials
Jianxi Xu, Yuning Wang, Yu Xu, et al.
Cancer Research
|
April 23, 2009
FOXP3 defines regulatory T cells in human tumor and autoimmune disease
Ilona Kryczek, Rebecca Liu, Guobin Wang, et al.
Journal of the American Chemical Society
|
February 22, 2022
Copper-Based Metal-Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis
Jia Liu, Ye Yuan, Yanni Cheng, et al.
Experimental Cell Research
|
October 16, 2019
AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer
Jing Li, Jia Hu, Zhen Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 2, 2025
Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy
Yao Lin, Xiong Sun, Chengguo Li, et al.
Scandinavian Journal of Gastroenterology
|
January 16, 2023
High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients
Wanjin Chen, Shouwen Wang, Hongchuan Zhao, et al.
Theranostics
|
June 6, 2022
Crosstalk between macrophage-derived PGE<sub>2</sub> and tumor UHRF1 drives hepatocellular carcinoma progression
Jian Zhang, Hongyan Zhang, Xiuli Ding, et al.
Functional & Integrative Genomics
|
February 3, 2023
Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma
Wanjin Chen, Haibo Wang, Yuanlong Shen, et al.
Frontiers in Oncology
|
September 26, 2022
Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial
Yuping Yin, Yao Lin, Ming Yang, et al.
BMC Gastroenterology
|
January 24, 2025
High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients
Shouwen Wang, Dachen Zhou, Wanjin Chen, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 274) with videos related to
Sort By:
Page
of 28
Advanced Materials (Deerfield Beach, Fla.)
|
March 30, 2026
Epitaxy Beyond Periodic Lattices: Interfacial Modulation Enabled by Defect State 2D Materials
Jianxi Xu, Yuning Wang, Yu Xu, et al.
Cancer Research
|
April 23, 2009
FOXP3 defines regulatory T cells in human tumor and autoimmune disease
Ilona Kryczek, Rebecca Liu, Guobin Wang, et al.
Journal of the American Chemical Society
|
February 22, 2022
Copper-Based Metal-Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis
Jia Liu, Ye Yuan, Yanni Cheng, et al.
Experimental Cell Research
|
October 16, 2019
AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer
Jing Li, Jia Hu, Zhen Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 2, 2025
Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy
Yao Lin, Xiong Sun, Chengguo Li, et al.
Scandinavian Journal of Gastroenterology
|
January 16, 2023
High level of tumor marker CA19-9 returned to normal after cholecystectomy in calculous cholecystitis patients
Wanjin Chen, Shouwen Wang, Hongchuan Zhao, et al.
Theranostics
|
June 6, 2022
Crosstalk between macrophage-derived PGE<sub>2</sub> and tumor UHRF1 drives hepatocellular carcinoma progression
Jian Zhang, Hongyan Zhang, Xiuli Ding, et al.
Functional & Integrative Genomics
|
February 3, 2023
Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma
Wanjin Chen, Haibo Wang, Yuanlong Shen, et al.
Frontiers in Oncology
|
September 26, 2022
Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial
Yuping Yin, Yao Lin, Ming Yang, et al.
BMC Gastroenterology
|
January 24, 2025
High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients
Shouwen Wang, Dachen Zhou, Wanjin Chen, et al.
Page
of 28